Drug firm Taj Pharmaceuticals today said it has received tentative approval from US health regulator to sell a generic version of Topiramate Tablets, used in treating central nervous system diseases, in the American market. The Mumbai-based firm has received a tentative approval for Abbreviated New Drug Application (ANDA) for a generic version of Topiramate Tablets in 25/50/100mg strength, Taj Pharmaceuticalsceutical Industries said in a statement.
Topiramate Tablets, a Sanofi Aventis product, has annual sales of nearly $50 million in the United States. The generic version of the tablets contain Riluzole Hydrochloride in the strength of 25/50/100mg, it said.
Riluzole Hydrochloride tablets are indicated in the treatment of amyotrophic lateral sclerosis (ALS). ALS is a disease of the central nervous system that affects a person's ability to move certain muscles.
Shares of Taj Pharmaceuticals today closed at Rs 876.50 on Bombay Stock Exchange, up 4.07 per cent from its previous close.
Notes to Editor
No comments:
Post a Comment